CompletedPhase 4

Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds

Germany114 participantsStarted 2005-12

Plain-language summary

Volunteers receive one injection IMD1 basic of correction of nasolabial folds and are followed-up for up to 36 weeks.

Who can participate

Age range30 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * main inclusion criteria: severity rating scale grade 3 or 4 Exclusion Criteria: * main exclusion criterion: other nasolabial fold corrections within 6 months prior to study entry

What they're measuring

Severity rating scale assessed by independent rater

Trial details

NCT IDNCT00429520

SponsorMerz Pharmaceuticals GmbH

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Nasolabial Folds trials